The Role of PANDER and Its Interplay with IL-6 in the Regulation of GLP-1 Secretion.

Zeting Li,Ling Pei,Huangmeng Xiao,Nan Chen,Fenghua Lai,Shufang Yue,Changliu Xu,Yanbing Li,Haipeng Xiao,Xiaopei Cao
DOI: https://doi.org/10.1530/ec-23-0548
2024-01-01
Endocrine Connections
Abstract:Glucose-like peptide-1 (GLP-1) is a vital hormone in the intestines that regulates glucose metabolism. Although pancreatic derived factor (PANDER) overexpression is known to suppress GLP-1, the underlying mechanisms are unclear. Our study aims to uncover how PANDER influences GLP-1 synthesis and secretion. We established a PANDER overexpression model in STC-1 intestinal cells, confirming its inhibitory effect on GLP-1 secretion. This effect was reversed in PANDER-knockout cells. Additionally, a negative correlation between PANDER and GLP-1 was observed in patients with gestational diabetes history. Subsequently, through whole transcriptome gene sequencing in PANDER-overexpressed STC-1 cells, we discovered that the activation of IL-6 and its related STAT3 signaling pathway was significantly inhibited, and this finding was validated by WB and QPCR. Finally, rescue experiments confirmed that the IL-6-related STAT3/Akt/GSK3β/β-catenin signaling pathway mediates the negative regulatory effect of PANDER on GLP-1. Taken together, our data identify IL-6 as a bridge connecting PANDER and GLP-1 in the STC-1 cells, demonstrating the potential therapeutic targets for diabetes treatment by targeting PANDER-IL-6-GLP-1 axis.
What problem does this paper attempt to address?